Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2010
04/20/2010US7700129 blend of anionic and cationic polymer such as methylenebisacrylamide/N,N*-/ crosslinked polysodium acrylate and polydimethylaminomethyl acrylate containing palladium or alloy electrodes capable of occluding and releasing and hydrogen electrochemically, such that the both polymeric gel change pH
04/20/2010US7700128 a layer containing pioglitazone or pioglitazone hydrochloride; and a layer containing glimepiride and a polyoxyethylene sorbitan fatty acid ester ; useful as a diabetes-treating agent and excellent in the dissolution properties of an insulin sensitizer and an insulin releasing pills
04/20/2010US7700124 Cosmetic compositions comprising a fine and porous powder
04/20/2010US7700122 Topical compositions comprising an opioid analgesic and an NMDA antagonist
04/20/2010US7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
04/20/2010US7700081 Psoriasis; applying daily to hair an aqueous mixture of clobetasol propionate, an anionic surfactant, an amphoteric surfactant, and ethanol; leaving it for 2.5 to 15 minutes, and rinsing with water.
04/20/2010US7700077 comprising from 1300 to 1500 mg/l of Na+, from 4500 to 6500 mg/l of K+, from 50 to 1300 mg/l of Mg++, from 20 to 350 mg/l of ca++, from 4000 to 6000 mg/l of Cl-, a pH of from 4-9, and an osmolality of from 150-700 mOsm/kg; for treating and cleaning the eye
04/20/2010US7700076 alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from urea, hydroxy acid and a therapeutic enhancer and a propellant; foam further comprises active agents and excipients
04/20/2010US7699834 Method and system for control of osmotic pump device
04/20/2010US7699833 Pump assembly and method for infusion device
04/20/2010US7699832 Medical device having a surface including a biologically active agent therein, and methods
04/20/2010US7699609 Dispensing apparatus and cartridge with deformable tip
04/20/2010CA2563185C Sustained release formulations of a peptide or protein and a purified gallic acid ester
04/20/2010CA2447926C Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
04/20/2010CA2433915C Improved controlled release oral dosage form
04/20/2010CA2433335C Particles for inhalation having sustained release properties
04/20/2010CA2432178C Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
04/20/2010CA2426764C Nateglinide-containing hydrophilic pharmaceutical preparation
04/20/2010CA2425338C Compositions comprising modafinil compounds
04/20/2010CA2417207C Dental products comprising bone growth enhancing peptide
04/20/2010CA2400172C Nanocapsule encapsulation system and method
04/20/2010CA2393159C Methods of treating tumors
04/20/2010CA2388240C Phenoxy carboxylic acid compounds and compositions for delivering active agents
04/20/2010CA2386826C Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for peritoneal dialysis
04/20/2010CA2379727C Use of propionic bacteria for producing propionic acid and/or propionates in the colon
04/20/2010CA2368334C Acidic gelled aqueous cosmetic compositions comprising oil-containing biliquid foam dispersion
04/20/2010CA2332701C Medium and matrix for long-term proliferation of cells
04/20/2010CA2319680C Compounds and compositions for delivering active agents
04/20/2010CA2299429C New lipopolyamines,their preparation and the use thereof
04/20/2010CA2279331C Compounds and compositions for delivering active agents
04/20/2010CA2180872C Composition containing nucleic acids, preparation and uses
04/20/2010CA2179779C Vaccine compositions comprising oil in water emulsions with tocopherol and squalene
04/20/2010CA2166208C Phosphazene polyelectrolytes as immunoadjuvants
04/20/2010CA1341603C Acidic polysaccharide esters and process for their preparation
04/15/2010WO2010042918A1 Biocompatible polymers for medical devices
04/15/2010WO2010042917A1 Phase-separated biocompatible polymer compositions for medical uses
04/15/2010WO2010042877A1 Improved amino lipids and methods for the delivery of nucleic acids
04/15/2010WO2010042823A1 Multifunctional self-assembling polymeric nanosystems
04/15/2010WO2010042701A2 Corticosteroid compositions and methods of treatments thereof
04/15/2010WO2010042553A1 Aerosol fluoroquinolone formulations for improved pharmacokinetics
04/15/2010WO2010042529A1 Oral transmucosal nicotine dosage form
04/15/2010WO2010042499A1 Stable solutions of orlistat for pharmaceutical dosage forms
04/15/2010WO2010042459A1 Topical formulations with a tertiary amine oxide
04/15/2010WO2010042432A1 Microspheres for the sustained release of octreotide with a low initial burst
04/15/2010WO2010042395A1 Benzimidazole anthelmintic compositions
04/15/2010WO2010042212A2 Methods for treating or preventing pain using spicamycin derivatives
04/15/2010WO2010042152A2 Amorphous rotigotine transdermal system
04/15/2010WO2010041983A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
04/15/2010WO2010041722A2 Pharmaceutical composition
04/15/2010WO2010041684A1 Tacrolimus preparation for external applications
04/15/2010WO2010041400A1 Biofilm formation inhibitor
04/15/2010WO2010041276A1 Pharmaceutical compositions comprising amorphous esomeprazole, dosage forms and process thereof
04/15/2010WO2010041256A2 A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
04/15/2010WO2010041255A2 Liposomal systems comprising sphingomyelin
04/15/2010WO2010041141A2 Oil-based foamable carriers and formulations
04/15/2010WO2010041100A1 Using of organic solvents in wet granulation of moxifloxacin
04/15/2010WO2010041096A1 Orally administrable immunostimulant product for aquaculture
04/15/2010WO2010041051A1 Pharmaceutical formulation 514
04/15/2010WO2010041017A2 Chewable gelled emulsions
04/15/2010WO2010041015A2 Chewable gelled emulsions
04/15/2010WO2010040789A1 Iron source product in the form of capsules and process for their preparation
04/15/2010WO2010040686A1 Method for producing controlled-release oral dosage forms
04/15/2010WO2010040683A1 Ready-to-use, stable emulsion
04/15/2010WO2010040652A1 Liquid pharmaceutical formulation containing paracetamol
04/15/2010WO2010040632A1 Modified release emulsions for application to skin or vaginal mucosa
04/15/2010WO2010040562A1 A polymer-free hydrogel
04/15/2010WO2010040254A1 The use of flavones from radix scutellariae in manufacture of medicaments for treating enterovirus infection
04/15/2010WO2010040173A1 A method of delivering functional agents across the blood-brain barrier
04/15/2010WO2010018593A3 Gastric acid resistant benzimidazole multiple unit tablet composition
04/15/2010WO2010013823A3 Pharmaceutical composition
04/15/2010WO2010013020A3 Sleeve for transdermal patches
04/15/2010WO2010009449A3 Extended release pharmaceutical formulations of s-adenosylmethionine
04/15/2010WO2010008203A3 Pharmaceutical formulation containing a calcium channel blocker
04/15/2010WO2009152222A3 Fluid bed meal containing a marker and methods of making
04/15/2010WO2009149136A3 Production of sustained release starch product
04/15/2010WO2009129460A4 Clonidine formulations in a biodegradable polymer carrier
04/15/2010WO2009087485A3 Topical compositions for delivery of proteins and peptides
04/15/2010WO2009009657A9 A composition to impart benefit agents to anionic substrates and methods of its use
04/15/2010US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
04/15/2010US20100094261 System and method for administering an infusible fluid
04/15/2010US20100094105 Piezoelectric transducer
04/15/2010US20100093796 Methods and devices for providing prolonged drug therapy
04/15/2010US20100093783 Composition for treatment of common cold
04/15/2010US20100093544 Adjuvant composition
04/15/2010US20100092572 Chitosan-based colloidal particles for rna delivery
04/15/2010US20100092571 Microcapsules having multiple shells and method for the preparation thereof
04/15/2010US20100092570 Controlled release oxycodone compositions
04/15/2010US20100092569 Product based on conjugated linoleic acid and a method for the manufacture thereof
04/15/2010US20100092568 Drug microparticles
04/15/2010US20100092567 Immunostimulatory nanoparticles and related compositions, methods and systems
04/15/2010US20100092566 Highly concentrated drug particles, formulations, suspensions and uses thereof
04/15/2010US20100092565 Pharmaceutical composition comprising microparticle oily suspension
04/15/2010US20100092564 Composition of and Method for Preparing Orally Disintegrating Tablets
04/15/2010US20100092563 Methods for the Preparation of Biologically Active Compounds in Nanoparticulate Form
04/15/2010US20100092562 Sustained-release drug delivery compositions and methods
04/15/2010US20100092561 Methods and compositions using substance p to promote wound healing
04/15/2010US20100092559 Boldine compounds for promoting bone growth
04/15/2010US20100092558 Method for Producing a Product Having a Polymer Matrix, Implants Made Thereof and Use Thereof
04/15/2010US20100092557 Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic
04/15/2010US20100092556 Alfuzosin formulations, methods of making, and methods of use
1 ... 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 ... 2991